(PCEC Rabies Vaccine)
Influenza vaccine (surface antigen, inactivated, prepared in cell
(Live Attenuated Varicella Virus Vaccine)
Freeze-dried Live Attenuated Hepatitis A Vaccine
(Japanese Encephalitis Vaccine, Live)
(Hepatitis B Vaccine (rDNA))
(Adsorbed Tetanus Vaccine)
Post exposure prophylaxis of tetanus: Tetanus infection may not confer immunity; therefore initiation or completion of active immunization is indicated at the time of recovery from this infection.
Neonatal tetanus prevention: If vaccination is required, tetanus toxoid can be used during pregnancy. Waiting until the second trimester to administer tetanus vaccine is a reasonable precaution for minimizing any concern regarding the theoretical possibility of adverse reactions.
Tetanus Prophylaxis in Wound Management: Tetanus toxoid can also be used prophylactically for wound management in persons 7 years of age and older.
Tetanus and Diphtheria vaccine
(adsorbed, reduced antigen content)
(Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed))
(Diphtheria and Tetanus Vaccine (Adsorbed, Reduced Antigen(s) Content))
(VACCINE AGAINST CHOLERA AND ETEC-DIARRHOEA)
Cholera: The vaccine is recommended for adults and children from 2 years of age who will be visiting areas with an ongoing or anticipated epidemic or who will be spending an extended period of time in areas in which cholera infection is a risk.
ETEC: The vaccine is recommended for adults and children from 2 years of age who will be visiting areas posing a great risk of diarrhoeal illness caused by enterotoxigenic Escherichia coli (ETEC).
(Tetanus vaccine, adsorbed)
• within the National Immunisation Programme:
- in case of contraindications for using: DTP, DT or Td vaccines,
- as a booster dose,
• in unvaccinated pregnant women,
• in active-passive prevention of tetanus in the case of contaminated wounds and at high risk of Clostridium tetani infection.